In addition, MVA- and HER2-specific IgG in CT26.HER2 tumor-bearing mice (Supplementary Fig. 8D, E) had no impact on MVA-HER2-CD40L-induced antitumor effects (Supplementary Fig. 8B) and prolonged survival of the animals (Supplementary Fig. 8C). This evidence concerns the gene CD40LG and neoplasm.